Wang, Hongwei <br/><br/>
Imatinib mesylate (STI-571) enhances antigen-presenting cell function and overcomes tumor-induced CD4+ T-cell tolerance.  [electronic resource] 

 -  Blood  Feb 2005 
 - 1135-43 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2004-01-0027  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amino Acid Sequence<br/>Animals<br/>Antigen-Presenting Cells--immunology<br/>Antineoplastic Agents--pharmacology<br/>Benzamides<br/>Bone Marrow Cells--immunology<br/>CD4-Positive T-Lymphocytes--immunology<br/>Dendritic Cells--drug effects<br/>Imatinib Mesylate<br/>Immune Tolerance--drug effects<br/>Lymphoma--immunology<br/>Macrophages--drug effects<br/>Mice<br/>Mice, Inbred BALB C<br/>Molecular Sequence Data<br/>Neoplasms--drug therapy<br/>Ovalbumin--chemistry<br/>Peptide Fragments--chemistry<br/>Piperazines--pharmacology<br/>Pyrimidines--pharmacology